David Cork is a Cardiology physician affiliated with Scripps Green Hospital. OpenAlex indexes 52 publications with 383 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9898 Genesee Ave
La Jolla, CA 920371205
Telephone
858-824-5222Provider last certified this registry record 19 Mar 2020.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20254 payments
- Abbott LaboratoriesProgram year202512 payments
- Medtronic, Inc.Program year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.6%Statin19.2%Atorvastatin Calcium56%Rosuvastatin Calcium39%Pravastatin Sodium4%Simvastatin1%Part D<11 patientsBeta blocker13.3%Metoprolol Succinate46%Metoprolol Tartrate23%Carvedilol20%Sotalol6%Nebivolol Hcl2%Atenolol2%Part D<11 patients+ 18 more classes in this area
Blood & clotting
8.9%Factor Xa inhibitor8%Eliquis84%Xarelto16%Part D≥93 patientsP2Y12 inhibitor0.9%Clopidogrel100%Part D≥16 patientsMetabolism & gastrointestinal
2.2%SGLT2 inhibitor1.9%Jardiance64%Farxiga36%Part D<11 patientsPotassium supplement0.2%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-9759-ACC RANOLAZINE-INDUCED THROMBOCYTOPENIA AND NEUTROPENIA: A CASE REPORT
Journal of the American College of Cardiology
2026 - Racial and ethnic differences in diagnosis, healthcare utilization and 1-year outcomes for patients with significant tricuspid regurgitation
Journal of Comparative Effectiveness Research
2025 - B-35 | Race/Ethnicity, and Other Predictors of Clinical Outcomes in the Year Following a Diagnosis of Severe or Clinically Significant Tricuspid Regurgitation
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - HEALTHCARE UTILIZATION TRENDS BY RACE AND ETHNICITY IN THE YEARS LEADING UP TO A DIAGNOSIS OF SEVERE OR CLINICALLY SIGNIFICANT TRICUSPID REGURGITATION
Journal of the American College of Cardiology
2025 - PULMONARY HYPERTENSION INCREASES PREOPERATIVE RISK OF SEDATION: PROPOFOL LEADING TO HEMODYNAMIC COMPROMISE
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Munveer Bhangoo, MD
Scripps Green Hospital
Christopher Uchiyama, MD
Scripps Green Hospital
Emily Singh, MD
Scripps Green Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”